NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









US Kidney Research Corporation

US Kidney Research Corporation

Private
Roseville, CaliforniaHealthcare & Life Scienceshttps://www.uskidneyresearchcorp.com/

Last Round

Grant

Nov 11, 2021

Total Funding Raised

$725,000

Company Overview

US Kidney Research Corporation is a medical research company developing waterless blood purification technology intended to replace traditional dialysis methods.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Biotechnology

Business Model

B2B

Customer Profile

Services & Consulting, Hardware Sales

AI Layer

Non-AI

Keywords

artificial kidneyrenal replacement therapydialysis alternativeend-stage renal diseaseESRDwaterless dialysisimplantable medical deviceultrafiltration membraneelectro-deionizationportable dialysisbioartificial kidneyacute kidney injuryAKImedical device R&Dwearable kidney

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

US Kidney Research Corporation Comparables

Compare US Kidney Research Corporation with similar companies based on industry and business-model similarity.

US Kidney Research Corporation comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Qidni Labs
86%
Nephrodite, Inc.
85%
Diality
82%

US Kidney Research Corporation Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantNov 11, 2021
GrantApr 1, 2019

US Kidney Research Corporation Investors

Notable investors and investment history

US Kidney Research Corporation investors
InvestorRounds
U.S. Department of Health and Human ServicesGrant
Kidney Innovation AcceleratorGrant

Market signals

Structured signals derived from secondary market and firmographic data.

  • Nov 11, 2021

    $650K grant led by Kidney Innovation Accelerator.

  • Apr 1, 2019

    $75K grant from Kidney Innovation Accelerator and others.

US Kidney Research Corporation Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

US Kidney Research Corporation Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about US Kidney Research Corporation's valuation, stock price, and market status.

Firmographic Details

HeadquartersRoseville, California
Year Founded2015
Last FundingNov 11, 2021

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.